Kingston, Canada

Rade Gadzic

This inventor holds 1 USPTO granted patent. Top assignee: Octane Biotech Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rade Gadzic. Retrieved from https://idiyas.com/inventor/rade-gadzic-x57u6cnu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rade Gadzic and Cell Engineering Support Structures.

Introduction

Rade Gadzic is an inventor associated with Kingston, Canada, and Octane Biotech Inc. His work includes a patented support structure designed for automated cell engineering systems.

Latest Patents

Gadzic is named on 1 patent, titled “Support Structures for Automated Cell Engineering Systems.” The invention concerns storage structures that can hold multiple automated cell engineering systems in one framework. The systems can be presented for direct access when needed and returned to a storage or working position afterward. The structures can be arranged together in clinical, hospital, or other cell therapy manufacturing environments.

Career Highlights

The patent reflects work on organizing and accessing automated cell engineering equipment. Its proposed structure is intended to support practical use of these systems in settings where cell therapy is developed or manufactured.

Collaborations

Gadzic’s listed coworkers include Scott Parsons and Mike Loveless. His patent is associated with Octane Biotech Inc.

Conclusion

Rade Gadzic’s patented support structure addresses the storage and accessibility of automated cell engineering systems, with potential applications in clinical and cell therapy manufacturing environments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…